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Summary The presence of lymph node metastasis in the neck of patients with head and neck
cancer is an important prognostic determinant. Therefore, metastatic nodes should be effec-
tively differentiated from non-metastatic reactive nodes, and a rapid and sensitive imaging
technique is essential in staging cancers and planning surgery and chemo- and radiotherapy for
cancer patients. MR imaging, positron emission tomography (PET), and CT may be useful in the
surveillance of the neck disease in such patients. In this report, we reviewed the whole-neck
imaging techniques for the effective screening of necks in patients with head and neck cancer.
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Staging neck metastasis is a crucial step in managing patients
with head and neck squamous cell carcinoma (HNSCC). The
presence of lymph node metastasis in the neck in patients
with HNSCC is an important prognostic determinant in staging
cancers and in planning radiotherapy for the cancer patients.
High-resolution imaging techniques provide information
about the changes in nodal architectures that are character-
istic ofmetastatic nodes; for example, nodal necrosis (or focal
defect) and obliteration of fat tissue in the hilum were effec-
tively depicted by MR imaging and US [1—5]. However, these
high-resolution imaging examinations may be cumbersome
and ineffective due to limited examination time. Therefore,
image acquisition time is a critical factor not only for high-
resolution imaging, but also for a high through-put of the* Corresponding author. Tel.: +81 95 819 7707; fax: +81 95 819 7711.
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would be beneficial for the screening of metastatic nodes in
the neck. Additional detailed imaging examinations using MR
and ultrasonography could be more efficient after such a
screening of the neck. It should also be noted that cost,
sensitivity, and hazards of radiation are considered in selecting
screening modalities.
2. MR imaging
2.1. Direct coronal fast spin-echo short inversion
time inversion-recovery sequence
Fast spin-echo short inversion time inversion-recovery (STIR)
is highly sensitive in detecting pathologic changes of lesions
[6]. This is because most pathologic tissues are proton rich
and have prolonged T1 relaxation and T2 decay times, result-
ing in high signal intensity on STIR images.
STIR imaging can be applied to whole-body MR imaging
that allows imaging of the entire body in a reasonable timel Science. Published by Elsevier Ireland. All rights reserved.
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static nodes in various cancers; in a previous study, STIR
imaging for the detection of metastasis in the mediastinal
and hilar nodes of patients with non-small cell lung cancer
yielded 93% sensitivity and 87% specificity on a per-patient
basis [9]. A more recent study on patients with HNSCC
demonstrated that STIR imaging along with the size criteria
yielded compromised diagnostic ability with 100% sensitivity
and 100% negative predictive value on a neck level basis [10].
However, normal and pathologic lymph nodes show similar
high signal intensity. Therefore, the STIR technique cannot be
used to differentiate between benign and malignant nodes
when the obtained imaged data are interpreted only on the
basis of the signal intensity of pathologic lesions. However, if
the nodal sizes are also evaluated, the STIR technique could
be applicable as a screening technique for metastatic nodes
in the neck [10]. In addition, metastatic nodes in patients
with HNSCC often exhibit nodal necrosis, which is depicted as
very high signals in the nodes; this feature could be used as a
pathognomonic indicator for metastatic nodes in patients
with HNSCC [1—5].
A major shortcoming of the STIR technique is that back-
ground signals from blood vessels are not suppressed. There-
fore, coronal STIR imaging with a long TE (for example,Figure 1 50-Year-old man with maxillary cancer. (A) Direct
coronal STIR image (TR/TE/TI/NSA = 3850 ms/80 ms/180 ms/2)
shows metastatic node with nodal necrosis at neck level IIA
(arrow). (B) Reconstructed coronal DWIBS (TR/TE/TI/
NSA = 5000 ms/67 ms/180 ms/3) image shows the same meta-
static node (arrow) as in (A). Nodal necrosis is not evident on this
MIP image. Arrowhead indicates primary SCC in the upper gingi-
val. SC, spinal cord; B, brain.80 ms) would be preferred, because this sequence well
delineates the blood vessels in the neck and reduces the
background signals, such as those from the muscles, more
effectively than a sequence with a shorter TE [10] (Fig. 1A).
The coronal STIR technique can detect metastatic nodes as
effectively as the axial fat-suppressed T2-weighted imaging.
However, the coronal STIR technique has a faster image
acquisition time and relative refractoriness to susceptibility
artifacts when compared with the fat-suppressed T2-
weighted technique; these are advantages of the coronal
STIR technique over the fat-suppressed T2-weighted techni-
que as a screening tool for the detection of metastatic nodes
in the neck.
2.2. Diffusion-weighted MR imaging with
suppressed background signals
Diffusion-weighted imaging with the single-shot STIR-echo-
planar technique could be useful as a whole-neck imaging.
Takahara et al. have recently introduced STIR-based diffu-
sion-weighted MR imaging with suppressed background sig-
nals (DWIBS), where the background body signals from the
vessels, muscles, and fat were effectively suppressed by the
diffusion-weighted and/or the STIR pulse [11]. Indeed, phase
ghosting artifacts on direct coronal STIR images of the neck
are frequently observed in the neck.
However, necrotic areas in metastatic nodes in patients
with HNSCC often lack signals on DWIBS images (Fig. 1B);
these necrotic regions could interfere with the effective
detection of metastatic nodes in the neck [10]. The limita-
tions of the DWIBS technique include (1) its susceptible to
motion artifacts, particularly at higher magnetic field
strengths, such as imaging at 3.0 T, resulting in stripe arti-
facts discernible on coronal and sagittal MIP images; (2)
DWIBS images do not provide accurate anatomical locations
of the lesions; and (3) tumor images on DWIBS may be less
specific due to T1 and/or T2 shine-through effects [12].
Notwithstanding these shortcomings, the DWIBS technique
could be a clinically feasible screening tool for tumor detec-
tion and lymph node imaging in the neck.
3. PET
PET is often used as a fusion imaging with CT (PET/CT) to
improve the anatomical localization of neck lesions [13]
(Fig. 2). PET is also a useful technique for the detection of
metastatic nodes in the neck. The superiority of the PET/
CT over MR imaging or ultrasonography (US) is still con-
troversial [14—16]. For example, PET may demonstrate
increased uptake in non-metastatic nodes of the neck
due to reactive B-lymphocyte proliferation in germinal
centers of the reactive nodes [17]. It was previously
reported that PET provided high sensitivity and negative
predictive values (100%), but its specificity and positive
predictive value were low (16.7% and 37.5%, respectively)
[15]. MR imaging and US were reported to yield much
higher specificities and negative predictive values in
detecting metastatic nodes of the neck, whereas their
sensitivities and positive predictive values were lower than
those of PET [5]. The high sensitivity and negative pre-
dictive values provided by PET are suitable for surveillance
of the neck in patients with HNSCC. However, it should be
Figure 2 62-Year-old man with cancer in buccal mucosa. (A) Coronal PET image shows high uptake area (SUV = 3.2) in the neck
(arrow). (B) Coronal PET/CT fusion image shows metastatic node at level IIA.
Figure 3 82-Year-old man with oropharyngeal cancer. Con-
trast-enhanced coronal reformatted CT shows 3 metastatic
nodes with necrotic foci (arrows) at level IIA.
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dictive values reported by those studies were calculated on
the node level basis, and not the node basis. In addition,
the image resolution of PET is much lower than those of MR
imaging and US. As in the cases of MR imaging and US, the
detection of metastatic nodes is dependent on nodal size
[18,19]; the incidence of false-positive results was higher
for nodes with short-axis diameters less than 10 mm, and
the cutoff values using standardized uptake value (SUV)
positively correlated with the nodal size.
Management of clinically negative necks (N0) has been
controversial issues in HNSCC, and the assessment of the N0
neck by different radiologic techniques has been extensively
studied. Therefore, the next question is whether PET could
effectively detect metastatic nodes in N0 necks. Scho¨der
et al. demonstrated that true-positive and false-positive
nodes exhibited similar SUVs, and that the sensitivity and
specificity were 67% and 95%, respectively, on the basis of
node level [20]. On the other hand, a follow-up study of 58 N0
patients with HNSCC demonstrated that a combination of CT
and Doppler US yielded 87% sensitivity, 100% specificity, and
100% positive and 99% negative predictive values as assessed
on the node basis [4]. Therefore, despite a reasonably high
overall accuracy, the application of PET to N0 necks may be
limited due to its low sensitivity for small metastatic nodes
and a high number of false-positive results [21].
4. Multidetector CT
Multidetector CT (MDCT) enables high-resolution (submilli-
meter) image acquisition of the whole neck within 20 s,
thereby allowing isotropic image reconstruction of the neck
in arbitrarily chosen planes [22]. A hallmark of metastatic
nodes in patients with HNSCC is the presence of nodal
76 T. Nakamura et al.necrosis [5]. Therefore, effective contrast enhancement is
essential for the diagnosis of metastatic nodes in the neck
(Fig. 3). A significant problem in the application of MDCT to
the neck surveillance for metastatic nodes may be an
increase in reconstruction and hundreds of images to review,
which would diminish the productivity of a radiologist. To
date, no comprehensive studies have yet been performed on
whole-neck imaging by MDCT for the screening of metastatic
nodes in patients with head and neck cancer. However, a
recent study has shown that multiplanar evaluation and
conventional 3-mm axial evaluation of head and neck MDCT
both allows for accurate tumor staging with regard to tumor
size and extent of tumor invasion into the surrounding struc-
tures and that no significant difference was found between
the 2 methods [23].
A discussion of the imaging techniques for detailed assess-
ment of individual metastatic and non-metastatic nodes is
beyond the scope of this review. Instead, we would like to
discuss the detection of sentinel lymph nodes (SLNs) in the
neck. SLN mapping has become an important tool for neck
staging and for minimally invasive surgery in patients with
early-stage head and neck cancer [24]. Currently, SLN map-
ping and biopsy is performed intraoperatively by using scinti-
graphy in combination with blue dye staining to facilitate
localization of the SLN. However, this technique is cumber-
some and has several limitations, primarily due to its low
spatial resolution and the lack of detailed anatomy of the
surrounding structures [25].
MDCT lymphography (MDCT-LG) has been applied to visua-
lize the lymphatics in patients with lung or breast cancer
[26,27]. This new technique enables the visualization of
drainage lymphatic pathways on 3D MDCT-LG images and
demonstrates the direct connection between an SLN(s) and
peritumor sites of contrast medium injection. For example,
the 3D MDCT-LG-guided SLN biopsy technique yielded 92%
sensitivity, a 7% false negative rate, and 98% accuracy in
patients with breast cancer [27]. Although the 3D MDCT-LG
technique has not yet been applied in the detection of SLNs in
the neck, it could be a promising technique for screening
metastatic nodes in the neck when combined with other
imaging techniques such as MR imaging.
5. Fusion imaging of MR and PET
Because of the high tissue contrast by MR imaging, the fusion
of MR and PET images may provide better delineation of the
lymph node than the fusion of CTand PET images. At present,
the inline PET/MR system is still under development. How-
ever, a preliminary study showed that in 3 of 46 patients with
HNSCC, the MR imaging alone and PET/MR fusion imaging
yielded different results; 1 patient with a true-positive neck
on MR imaging alone was diagnosed as negative by PET/MR
fusion imaging and 2 patients with false-positive necks were
diagnosed correctly by the fusion imaging [28]. Further
technical innovations are required for establishing PET/MR
fusion imaging as a surveillance tool in the necks of patients
with HNSCC.
6. Conclusion
Several techniques are available for whole-neck imaging for
screening metastatic nodes in patients with HNSCC. Recentadvances in imaging techniques and post-imaging processing
have enabled effective diagnosis of metastatic nodes in the
neck. However, these techniques still have pros and cons.
Clinicians should bear the characteristics of each imaging
technique in mind and tailor such techniques to the specific
needs of individual patients.
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